A critical appraisal of existing concepts for the grouping of nanomaterials
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The grouping of substances serves to streamline testing for regulatory purposes. General grouping approaches for chemicals have been implemented in, e.g., the EU chemicals regulation. While specific regulatory frameworks for the grouping of nanomaterials are unavailable, this topic is addressed in different publications, and preliminary guidance is provided in the context of substance-related legislation or the occupational setting. The European Centre for Ecotoxicology and Toxicology of Chemicals Task Force on the Grouping of Nanomaterials reviewed available concepts for the grouping of nanomaterials for human health risk assessment. In their broad conceptual design, the evaluated approaches are consistent or complement each other. All go beyond the determination of mere structure-activity relationships and are founded on different aspects of the nanomaterial life cycle. These include the NM's material properties and biophysical interactions, specific types of use and exposure, uptake and kinetics, and possible early and apical biological effects. None of the evaluated grouping concepts fully take into account all of these aspects. Subsequent work of the Task Force will aim at combining the available concepts into a comprehensive 'multiple perspective' framework for the grouping of nanomaterials that will address all of the mentioned aspects of their life cycles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Perturbational profiling of nanomaterial biologic activity
Shaw, S. Y., Westly, E. C., Pittet, M. J., Subramanian, A., Schreiber, S. L., & Weissleder, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802878105 · Cited by 248
Cited by
Nanomedicine: Principles, Properties, and Regulatory Issues
Soares, S., Sousa, J., Pais, A., & Vitorino, C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00360 · Cited by 790
Regulatory aspects of nanotechnology in the agri/feed/food sector in EU and non-EU countries
Amenta, V., Aschberger, K., Arena, M., Bouwmeester, H., Botelho Moniz, F., Brandhoff, P., Gottardo, S., Marvin, H. J. P., Mech, A., Quiros Pesudo, L., et al. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.06.016 · Cited by 456
EFSA Scientific Committee, Hardy, A., Benford, D., Halldorsson, T., Jeger, M. J., Knutsen, H. K., More, S., Naegeli, H., Noteborn, H., Ockleford, C., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5327 · Cited by 416
EFSA Scientific Committee, More, S., Bampidis, V., Benford, D., Bragard, C., Halldorsson, T., Hernández‐Jerez, A., Hougaard Bennekou, S., Koutsoumanis, K., Lambré, C., et al. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6768 · Cited by 395
Photoluminescent Nanoparticles for Chemical and Biological Analysis and Imaging
Algar, W. R., Massey, M., Rees, K., Higgins, R., Krause, K. D., Darwish, G. H., Peveler, W. J., Xiao, Z., Tsai, H.-Y., Gupta, R., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01176 · Cited by 356
Integrated Approach of Agri-nanotechnology: Challenges and Future Trends
Mishra, S., Keswani, C., Abhilash, P. C., Fraceto, L. F., & Singh, H. B. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.00471 · Cited by 279
A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping)
Arts, J. H. E., Hadi, M., Irfan, M.-A., Keene, A. M., Kreiling, R., Lyon, D., Maier, M., Michel, K., Petry, T., Sauer, U. G., et al. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.03.007 · Cited by 256
Self-citationA perspective on the developmental toxicity of inhaled nanoparticles
Hougaard, K. S., Campagnolo, L., Chavatte-Palmer, P., Tarrade, A., Rousseau-Ralliard, D., Valentino, S., Park, M. V. D. Z., de Jong, W. H., Wolterink, G., Piersma, A. H., et al. (2015) · Reproductive Toxicology · doi:10.1016/j.reprotox.2015.05.015 · Cited by 171
Wiemann, M., Vennemann, A., Sauer, U. G., Wiench, K., Ma-Hock, L., & Landsiedel, R. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0164-2 · Cited by 152
Self-citationThe asbestos-carbon nanotube analogy: An update
Kane, A. B., Hurt, R. H., & Gao, H. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.06.027 · Cited by 106
In vivo effects: Methodologies and biokinetics of inhaled nanomaterials
Oberdörster, G., & Kuhlbusch, T. A. J. (2018) · NanoImpact · doi:10.1016/j.impact.2017.10.007 · Cited by 88
Marvin, H. J. P., Bouzembrak, Y., Janssen, E. M., van der Zande, M., Murphy, F., Sheehan, B., Mullins, M., & Bouwmeester, H. (2017) · Nanotoxicology · doi:10.1080/17435390.2016.1278481 · Cited by 82
“For this reason, dissolution properties are included in early stages of tiered risk assessment approaches (Arts et al., 2014, 2016).”
BackgroundCordelli, E., Keller, J., Eleuteri, P., Villani, P., Ma-Hock, L., Schulz, M., Landsiedel, R., & Pacchierotti, F. (2017) · Mutagenesis · doi:10.1093/mutage/gew005 · Cited by 35
Self-citation
Metadata
- Authors
- Arts, J. H. E., Hadi, M., Keene, A. M., Kreiling, R., Lyon, D., Maier, M., Michel, K., Petry, T., Sauer, U. G., Warheit, D., Wiench, K., & Landsiedel, R.
- Venue
- Regulatory Toxicology and Pharmacology
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 70
- Issue
- 2
- Pages
- 492-506
- ISSN
- 0273-2300 (ISSN-L)
- OpenAlex
- W2088467325
- Cited by
- 139
- References
- 3
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.